IRADIMED CORP Balance Sheet
IRMD / Health Care|13 years of annual SEC 10-K data (FY2013-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 13 fiscal years. All figures from audited SEC 10-K filings.
IRADIMED CORP had $109M in total assets and $95M in shareholders' equity as of FY2025.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score 5.29 (safe zone, above 2.9 threshold)
- Strong profit margin: 24.1%
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $51.2M | $52.2M | $49.8M | $58.0M | $62.0M | $50.1M | $43.5M | $28.0M | $18.2M | $17.7M | $19.4M | $2.5M | $2.5M |
| Accounts Receivable | $13.7M | $10.6M | $12.2M | $13.3M | $5.1M | $4.6M | $7.3M | $4.2M | $3.8M | $3.8M | $3.9M | $2.0M | $2.0M |
| Inventory | $11.6M | $10.4M | $12.8M | $5.4M | $4.3M | $3.9M | $3.6M | $4.1M | $4.2M | $3.9M | $2.4M | $2.1M | $1.3M |
| Current Assets | $81.2M | $75.2M | $76.0M | $77.5M | $76.2M | $63.7M | $59.0M | $44.5M | $35.1M | $34.2M | $34.0M | $22.2M | $6.4M |
| PP&E (Net) | $23.9M | $16.8M | $9.3M | $2.4M | $2.1M | $2.1M | $2.1M | $1.9M | $1.9M | $1.5M | $905.6K | $794.8K | $327.3K |
| Total Assets | $108.8M | $98.3M | $92.2M | $85.5M | $82.9M | $71.1M | $66.7M | $48.4M | $39.0M | $37.2M | $35.2M | $23.3M | $7.0M |
| Current Liabilities | $10.2M | $8.5M | $16.3M | $8.6M | $6.8M | $4.9M | $5.9M | $4.7M | $4.1M | $3.7M | $2.9M | $2.3M | $1.5M |
| Shareholders' Equity | $94.6M | $86.8M | $71.4M | $72.2M | $72.2M | $61.4M | $55.5M | $41.9M | $32.9M | $31.9M | $31.9M | $5.4M | $5.4M |